FDA: lower ambien's dose to prevent drowsy driving
(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...
Medications
May 15, 2013 |
not rated yet |
0
FDA denies request to block generic painkiller
In a surprise move, federal health regulators have denied a request by Endo Health Solutions to block generic versions of its painkiller Opana ER, which the company argued can be more easily abused than its branded product.
Medications
May 10, 2013 |
not rated yet |
0
Drug manufacturer agrees to $500 million penalty (Update)
A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...
Medications
May 13, 2013 |
not rated yet |
0
FDA warns pregnant women about migraine drugs
(HealthDay)—Pregnant women who struggle with migraine headaches should never use medicines containing the ingredient valproate because they can lower the IQ scores of their children, the U.S. Food and Drug ...
Medications
May 06, 2013 |
not rated yet |
0
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. ...
Medications
Apr 01, 2013 |
not rated yet |
0
Supreme Court ruling supports generic drug makers
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Medications
Apr 18, 2012 |
5 / 5 (1) |
0
Switching antiepileptic drugs could increase risk of seizures
The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy.
Medications
Feb 17, 2012 |
5 / 5 (2) |
0
|
Soviet-era pill from Bulgaria helps smokers quit
(AP) -- A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.
Health
Sep 28, 2011 |
4.5 / 5 (2) |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
India's top court to deliver Novartis judgment
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies ...
Medications
Mar 31, 2013 |
not rated yet |
0
Canada high court voids Pfizer's Viagra patent
Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.
Medications
Nov 08, 2012 |
not rated yet |
0
First generic version of cancer drug Doxil approved
(HealthDay)—The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages ...
Medications
Feb 04, 2013 |
not rated yet |
0
Hoping to ease shortage, FDA fast-tracks generic form of cancer drug
(HealthDay)—Seeking to ease potentially dangerous shortages of a key cancer drug, the U.S. Food and Drug Administration on Monday announced it had fast-tracked the approval of the first generic form of ...
Medications
Feb 04, 2013 |
not rated yet |
0
US says Teva antidepressant is ineffective
(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.
Medications
Oct 03, 2012 |
5 / 5 (1) |
0
